These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 20127861)
1. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide. Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861 [TBL] [Abstract][Full Text] [Related]
2. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway. Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296 [TBL] [Abstract][Full Text] [Related]
3. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion. Johnson-Holiday C; Singh R; Johnson EL; Grizzle WE; Lillard JW; Singh S World J Surg Oncol; 2011 May; 9():46. PubMed ID: 21539750 [TBL] [Abstract][Full Text] [Related]
4. CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma Chai S; Wen Z; Zhang R; Bai Y; Liu J; Li J; Kongling W; Chen W; Wang F; Gao L PeerJ; 2022; 10():e13844. PubMed ID: 36003306 [TBL] [Abstract][Full Text] [Related]
5. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines. Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282 [TBL] [Abstract][Full Text] [Related]
6. CCR9 and CCL25: A review of their roles in tumor promotion. Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349 [TBL] [Abstract][Full Text] [Related]
7. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes. Atanes P; Lee V; Huang GC; Persaud SJ Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852 [TBL] [Abstract][Full Text] [Related]
8. CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion. Johnson EL; Singh R; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW; Singh S J Ovarian Res; 2010 Jun; 3():15. PubMed ID: 20565782 [TBL] [Abstract][Full Text] [Related]
9. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease. Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426 [TBL] [Abstract][Full Text] [Related]
10. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation? Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408 [TBL] [Abstract][Full Text] [Related]
11. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913 [TBL] [Abstract][Full Text] [Related]
12. Blocking of c-FLIP(L)--independent cycloheximide-induced apoptosis or Fas-mediated apoptosis by the CC chemokine receptor 9/TECK interaction. Youn BS; Kim YJ; Mantel C; Yu KY; Broxmeyer HE Blood; 2001 Aug; 98(4):925-33. PubMed ID: 11493434 [TBL] [Abstract][Full Text] [Related]
13. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989 [TBL] [Abstract][Full Text] [Related]
14. Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660 [TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Yu HG; Ai YW; Yu LL; Zhou XD; Liu J; Li JH; Xu XM; Liu S; Chen J; Liu F; Qi YL; Deng Q; Cao J; Liu SQ; Luo HS; Yu JP Int J Cancer; 2008 Jan; 122(2):433-43. PubMed ID: 17935137 [TBL] [Abstract][Full Text] [Related]
16. CCR9 in cancer: oncogenic role and therapeutic targeting. Tu Z; Xiao R; Xiong J; Tembo KM; Deng X; Xiong M; Liu P; Wang M; Zhang Q J Hematol Oncol; 2016 Feb; 9():10. PubMed ID: 26879872 [TBL] [Abstract][Full Text] [Related]
17. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434 [TBL] [Abstract][Full Text] [Related]
18. Thymus-expressed chemokine promotes survival of PC12 cells via PI3K pathway. Cao X; Ma J; Wu G; Zhang C; Wang L; Dai S; Xu W Neurochem Int; 2012 Jan; 60(2):163-9. PubMed ID: 21672573 [TBL] [Abstract][Full Text] [Related]
19. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice. Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795 [TBL] [Abstract][Full Text] [Related]
20. CCL25 chemokine-guided stem cell attraction: an assessment of possible benefits and risks. Spinnen J; Ringe J; Sittinger M Regen Med; 2018 Oct; 13(7):833-844. PubMed ID: 30284497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]